These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 21088574)
21. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. Navarro-Díaz M; Serra A; Romero R; Bonet J; Bayés B; Homs M; Pérez N; Bonal J J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S213-7. PubMed ID: 17130264 [TBL] [Abstract][Full Text] [Related]
22. Obesity-related glomerulopathy in China: a case series of 90 patients. Chen HM; Li SJ; Chen HP; Wang QW; Li LS; Liu ZH Am J Kidney Dis; 2008 Jul; 52(1):58-65. PubMed ID: 18423814 [TBL] [Abstract][Full Text] [Related]
23. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Chalmers L; Kaskel FJ; Bamgbola O Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221 [TBL] [Abstract][Full Text] [Related]
24. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Cho MH; Hong EH; Lee TH; Ko CW Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521 [TBL] [Abstract][Full Text] [Related]
25. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy. Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274 [TBL] [Abstract][Full Text] [Related]
30. Podocyte lesions in patients with obesity-related glomerulopathy. Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996 [TBL] [Abstract][Full Text] [Related]
32. Obesity, insulin resistance and kidney disease risk: insights into the relationship. Sarafidis PA Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384 [TBL] [Abstract][Full Text] [Related]
33. Kidney disease in the obese patient. Naguib MT South Med J; 2014 Aug; 107(8):481-5. PubMed ID: 25084184 [TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem. Iseki K J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718 [TBL] [Abstract][Full Text] [Related]
35. Obesity and target organ damage: the kidney. de Jong PE; Verhave JC; Pinto-Sietsma SJ; Hillege HL; Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S21-4. PubMed ID: 12457295 [TBL] [Abstract][Full Text] [Related]
36. Renal manifestations in the metabolic syndrome. Locatelli F; Pozzoni P; Del Vecchio L J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254 [TBL] [Abstract][Full Text] [Related]
37. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Korbet SM Semin Nephrol; 2003 Mar; 23(2):219-28. PubMed ID: 12704582 [TBL] [Abstract][Full Text] [Related]
38. [Two cases of idiopathic membranous nephropathy with focal and segmental glomerulosclerotic lesions in which renal function progressively deteriorated]. Suzuki R; Morita H; Mizobuchi M; Nemoto T; Sato Y; Niikura K; Ideura T; Yoshimura A Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):381-7. PubMed ID: 10998919 [TBL] [Abstract][Full Text] [Related]
39. [Obesity: what impact on renal function?]. Mathieu C; Teta D; Vogt B; Burnier M Rev Med Suisse; 2006 Mar; 2(55):576-8, 580-1. PubMed ID: 16562600 [TBL] [Abstract][Full Text] [Related]
40. [Metabolic syndrome related kidney injury]. Chen YP Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(30):2093-4. PubMed ID: 17064609 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]